Get started
Author

Francesca Ambrosio

Italian, Multicenter, Phase III, Randomized Study of Cisplatin Plus Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive-Disease Small-Cell Lung Cancer: The GOIRC-AIFA FARM6PMFJM Trial
2017 · Marcello Tiseo, Luca Boni, et al. · Journal of Clinical Oncology · 178
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples
2018 · Francesco Pepe, Caterina De Luca, et al. · Journal of Clinical Pathology · 45
Neutrophil-to-Lymphocyte Ratio Is a Major Prognostic Factor in Non-small Cell Lung Carcinoma Patients Undergoing First Line Immunotherapy With Pembrolizumab
2022 · FRANCESCO JACOPO ROMANO, RICCARDO RONGA, et al. · Cancer Diagnosis & Prognosis · 30
PDF
Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy
2024 · Vito Longo, Carminia Maria Della Corte, et al. · Frontiers in Immunology · 27
EGFR mutation detection on routine cytological smears of non-small cell lung cancer by digital PCR: a validation study
2016 · Umberto Malapelle, Caterina de Luca, et al. · Journal of Clinical Pathology · 24
Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma
2019 · Francesco Morra, Francesco Merolla, et al. · Lung Cancer · 20
Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial
2014 · Marcello Tiseo, Luca Boni, et al. · Clinical Lung Cancer · 19
Nivolumab in never-smokers with advanced squamous non-small cell lung cancer: Results from the Italian cohort of an expanded access program
2018 · Marina Chiara Garassino, Lucio Crinò, et al. · Tumor Biology · 9
PDF
Therapy innovation for the treatment of pancreatic neuroendocrine tumors
2012 · Ferdinando Riccardi, Mimma Rizzo, et al. · Expert Opinion on Therapeutic Targets · 7
Horner’s syndrome: An unusual presentation of metastatic disease in breast cancer
2015 · Maria Giuseppa Vitale, Ferdinando Riccardi, et al. · International Journal of Immunopathology and Pharmacology · 5
PDF
RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy
2024 · Pasquale Pisapia, Antonino Iaccarino, et al. · Pathologica · 3
PDF
First-Line Chemotherapy with Liposomal Doxorubicin Plus Cyclofosfamide in Metastatic Breast Cancer: A Case Report of Early and Prolonged Response
2013 · F. Riccardi, C. Mocerino, et al. · International Journal of Immunopathology and Pharmacology · 3
PDF
Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trial
2016 · M. Tiseo, L. Boni, et al. · Annals of Oncology · 2
Italian multicenter phase III randomized study of cisplatin-etoposide with or without bevacizumab as first-line treatment in extensive stage small cell lung cancer (SCLC): GOIRC-AIFA FARM6PMFJM trial.
2016 · Marcello Tiseo, Luca Boni, et al. · Journal of Clinical Oncology · 2
Long Progression-free Survival with Afatinib in a Patient with EGFR-unknown Lung Adenocarcinoma after Erlotinib Failure: A Case Report
2015 · Maria Giuseppa Vitale, Sarah Scagliarini, et al. · Tumori Journal · 2
2001P Consolidative thoracic radiotherapy of extensive-stage small cell lung cancer in the era of chemoimmunotherapy: A retrospective analysis concerning patients from southern Italy
2023 · V. Longo, F. Vitiello, et al. · Annals of Oncology · 1
PDF
Folinic acid in colorectal cancer: esquire or fellow knight? Real-world results from a mono institutional, retrospective study
2021 · Francesco Jacopo Romano, Carmela Barbato, et al. · Oncotarget · 1
Additional file 4 of α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis
2026 · Francesca Romana Pellegrini, Angela Iuzzolino, et al. · Figshare
Additional file 1 of α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis
2026 · Francesca Romana Pellegrini, Angela Iuzzolino, et al. · Figshare
Additional file 2 of α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis
2026 · Francesca Romana Pellegrini, Angela Iuzzolino, et al. · Figshare
Additional file 5 of α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis
2026 · Francesca Romana Pellegrini, Angela Iuzzolino, et al. · Figshare
Additional file 3 of α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis
2026 · Francesca Romana Pellegrini, Angela Iuzzolino, et al. · Figshare
Additional file 7 of α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis
2026 · Francesca Romana Pellegrini, Angela Iuzzolino, et al. · Figshare
Additional file 6 of α-tubulin N-acetyltransferase 1 regulates NCOA4-mediated ferritinophagy and protects cancer cells from ferroptosis
2026 · Francesca Romana Pellegrini, Angela Iuzzolino, et al. · Figshare
P3.18.18 Predictive Role of Respiratory Function Tests on Lung Toxicity in Stage III NSCLC Under Chemo-Radiotherapy and Durvalumab: Preludio Trial
2025 · P.M. Medusa, C.M. Della Corte, et al. · Journal of Thoracic Oncology
Works count: 32
Citation count: 378
H-index: 8
I10-index: 7
Year
Topic
Type